Corticosteroids: Triamcinolone, Dexamethasone and Fluocinolone

Corticosteroids: Triamcinolone, Dexamethasone and Fluocinolone
复制标题

DOI:
10.1159/000431198
复制
发表时间:
2016-01-01
期刊:
RETINAL PHARMACOTHERAPEUTICS
影响因子:
--
通讯作者:
Kuppermann, Baruch D.
Kuppermann, Baruch D.
中科院分区:
其他
文献类型:
--
作者:
Caceres-del-Carpio, Javier;Costa, Rodrigo Donato;Kuppermann, Baruch D.

文献摘要

被引文献

相似文献

类固醇已广泛用于治疗糖尿病视网膜病变、静脉闭塞性疾病、眼部炎症引起的黄斑水肿,并且在较小程度上也用于治疗脉络膜新生血管形成的某些病例。已使用的各种眼内类固醇包括地塞米松、曲安西龙和氟轻松。在过去的几年中,新的药物输送方法的皮质类固醇已经开发出来,现在是我们的治疗设备的一部分。本章简要介绍了类固醇在各种视网膜疾病中的药理学、疗效和不良反应。(C)2016 S. Karger AG,巴塞尔
Steroids have been extensively used to treat macular edema due to diabetic retinopathy, venous occlusive disease, ocular inflammation and, to a lesser extent, also in some cases of choroidal neovascularization. The various intraocular steroids that have been employed include dexamethasone, triamcinolone and fluocinolone. During the past few years, new drug delivery methods for corticosteroids have been developed and are now part of our therapeutic armamentarium. This chapter provides a brief description of the pharmacology, efficacy and adverse effects associated with the use of steroids in various retinal diseases. (C) 2016 S. Karger AG, Basel